Astrantus’s Humana HUM Stock Holding History

Astrantus’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,300	Closed	-$603K	–	232
2021 Q4	$603K	Buy	+1,300	New	+$575K	0.45%	95

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Astrantus's HUM Position: Q1 2022 in Review

Astrantus sold out of Humana (HUM) in Q1 2022, closing a stake of 1,300 shares — an estimated $603K sold.

Astrantus first reported a position in HUM in Q4 2021 and held it in 1 quarter. The position peaked at $603K in Q4 2021. 914 funds tracked by Wall St. Rank hold HUM as of Q1 2022.

Astrantus reported no remaining Humana position as of Q1 2022 after selling out during the quarter.
Astrantus sold 1,300 Humana shares in Q1 2022, an estimated $603K.
Astrantus first reported a position in Humana in Q4 2021 and held it in 1 quarter.
Astrantus's Humana position peaked at $603K in Q4 2021.
914 funds tracked by Wall St. Rank held Humana as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.